• Understanding the Transition Between Age-Specific Measures of Health-Related Quality of Life: Evidence on the Relationship Between and Comparative Performance of the EQ-5D-Y-5L and EQ-5D-5L

    Aug 1, 2025, 00:00

  • Exemption System for Economic Evaluation Data Submission for Pharmaceuticals in South Korea: Achievements and Challenges

    Aug 1, 2025, 00:00

  • Psychometric Properties of the Modified EQ Health and Wellbeing and its Shorter Version in a General Chinese Population: A Comparative Analysis With EQ-5D-5L, SF-6Dv2, ICEpop CAPability measure for Adults, Short Version of Warwick-Edinburgh ...

    Aug 1, 2025, 00:00

  • A Comparative Study of Health and Well-Being Measures in Ireland Using EQ Health and Wellbeing (EQ-HWB) and its Short Version, EQ-5D-5L, and ICEpop Capability Measure for Adults (ICECAP-A)

    Aug 1, 2025, 00:00

  • Early Budget Impact Analysis of Artificial Intelligence to Support the Review of Radiographic Examinations for Suspected Fractures in National Health Service Emergency Departments

    Aug 1, 2025, 00:00

  • Growing Evidence Base on Condition-Specific Patient-Reported Outcome Measures for Long COVID

    Aug 1, 2025, 00:00

  • Implementing the Generalized Risk-Adjusted Cost-Effectiveness Model for Sickle Cell Disease: A Case Study

    Aug 1, 2025, 00:00

  • Costs and Outcomes After Primary and Revision Hip Replacements by Implant Bearing Materials: Analysis of 550 760 linked Patient Records from English Routinely Collected Databases

    Aug 1, 2025, 00:00

  • Distributional Cost-Effectiveness Analysis in Genomic Medicine: Considerations for Addressing Health Equity

    Aug 1, 2025, 00:00

  • An Exploratory Study of Alternative Time Frames and Descriptors for EQ-5D-5L in Obstructive Airway Diseases Using Mixed Methods

    Aug 1, 2025, 00:00

  • The Increasing Use of Clinical Outcome Assessments in US Food and Drug Administration Labels and the German Gemeinsamer Bundesausschuss, National Institute for Health and Care Excellence, and the French Haute Autorité de Santé Assessments F ...

    Aug 1, 2025, 00:00

  • The Psychometric Performance of the EQ Health and Wellbeing in Caregivers of Persons Living With Dementia

    Aug 1, 2025, 00:00

  • Realizing the Economic Potential of Meditation and Mindfulness Practices in Mental Health Care

    Aug 1, 2025, 00:00

  • Synergizing Needs Assessments and Patient Preference Studies for Enhanced Patient-Centered Decision Making in Healthcare

    Aug 1, 2025, 00:00

  • A Comprehensive View of the Methods Used to Measure the Societal Impact of Healthcare Interventions: A Systematic Review

    Aug 1, 2025, 00:00

  • The Value of Hope in Cancer Care: Risk Preference and Heterogeneity in Cancer Patients and the General Public

    Aug 1, 2025, 00:00

  • Table of Contents

    Aug 1, 2025, 00:00

  • Mapping EQ-5D-5L Utilities in Dementia: Integrating Self and Proxy Reports

    Aug 1, 2025, 00:00

  • The Functional Assessment of Cancer Therapy Eight Dimension (FACT-8D), a Multi-Attribute Utility Instrument Derived From the Cancer-Specific FACT-General (FACT-G) Quality of Life Questionnaire: Development and Australian Value Set

    Aug 1, 2025, 00:00

  • The Burden of Mitochondrial Disease: Healthcare and Societal Costs

    Aug 1, 2025, 00:00

  • Addressing Subgroup-Specific Treatment Effects to Avoid Inefficient Care: The Conflict Between Statistical and Health Economic Analyses

    Aug 1, 2025, 00:00

  • A Systematic Review and Meta-Analysis of Health-State Utility Values for Infectious Diseases With Pandemic Potential and Associated Vaccine Adverse Reactions

    Aug 1, 2025, 00:00

  • Editorial Board

    Jul 31, 2025, 08:55

  • SA17 Assessing the Impact of Frailty on Healthcare Burden Post-Surgery in Head and Neck Cancer Patients

    Jul 14, 2025, 17:02

  • Editorial Board

    Jul 3, 2025, 09:29

  • Statistical Methods for Analyzing EQ-5D in Randomized Clinical Trials: A Systematic Literature Review

    Jul 1, 2025, 00:00

  • HPR137 HTA Assessments for Multipurpose Contrast Agents: Insights and Solutions to Formal HTA Challenges

    Jul 1, 2025, 00:00

  • CO57 Comparative Clinical Effectiveness of Analgesics for the Treatment of Moderate-to-Severe Acute Pain: A Systematic Review and Network Meta-Analysis

    Jul 1, 2025, 00:00

  • EE490 Novel Value Elements: Developing and Applying a Pragmatic Framework in Early Stages of Product Development

    Jul 1, 2025, 00:00

  • MSR67 Prognostic Model for Overall Survival in Colorectal Cancer Patients in the US: A Real World Data Study

    Jul 1, 2025, 00:00

  • P31 Using Z Codes to Characterize Health and Social Histories in Commercially Insured Non-Hodgkin Lymphoma Patients: Insights from Real-World Data

    Jul 1, 2025, 00:00

  • EE245 Continuous Avoidance Cost in Biosimilar: A Budget Impact Analysis on the Basis of Clinical Trial Model and RWD in Brazil / LATAM / LMIC

    Jul 1, 2025, 00:00

  • P36 Comparative Analysis of Large Language Models for Extracting Patient-Reported Outcome Measures From Clinical Trial Protocols in Lymphoma

    Jul 1, 2025, 00:00

  • EE249 Quantifying the Financial Burden of HbA1c Levels: A Retrospective Single-Center Analysis of Healthcare Costs in South Korean Diabetes Patients

    Jul 1, 2025, 00:00

  • HPR3 Determinants of Clinical Trial Participation in Prostate Cancer Patients: A Nationwide Medicare Analysis

    Jul 1, 2025, 00:00

  • PCR146 Using Machine Learning to Identify Key Predictors of Health-Related Quality of Life in Older Women with Early-Stage Breast Cancer Undergoing Endocrine Therapy

    Jul 1, 2025, 00:00

  • PCR35 Health Utilities Associated With Pneumococcal Diseases in Children and Adults in the United States: A Targeted Literature Review and Meta-Analysis

    Jul 1, 2025, 00:00

  • EE266 Exploring the Broader Societal Value of Pembrolizumab in Triple-Negative Breast Cancer and Cervical Cancer in Brazil

    Jul 1, 2025, 00:00

  • MSR48 Discrete-Event Simulation Model Projects Economic Outcomes Associated with Long-Term Clinical Remission in Patients with Severe Asthma Receiving Mepolizumab

    Jul 1, 2025, 00:00

  • MSR87 Using Regression Discontinuity in Time Design for Real-World Comparative Effectiveness: A Case Study for the Second-Line Use of Pembrolizumab in Advanced Non-Small Cell Lung Cancer

    Jul 1, 2025, 00:00

  • HSD34 Telehealth for Disease Management: A Scoping Review of Effectiveness in the Perinatal Period

    Jul 1, 2025, 00:00

  • MSR8 Is Bayesian Statistics an Emerging Way for Extrapolating Survival in Cost-Effectiveness Analysis: A Systematic Review

    Jul 1, 2025, 00:00

  • RWD27 COVID Impact on Cardiac Implantable Eletronic Devices Trends in the Brazilian Public Health System: a Joinpoint Regression Analysis

    Jul 1, 2025, 00:00

  • RWD114 Real-World Characteristics and Treatment Patterns With Nintedanib in Patients With Idiopathic Pulmonary Fibrosis: A Retrospective US Claims Study

    Jul 1, 2025, 00:00

  • RWD11 Real-World Unmet Needs in Patients With HER2-Negative Advanced Gastric, Gastro-Esophageal or Esophageal Adenocarcinoma Receiving First-Line Treatment Globally

    Jul 1, 2025, 00:00

  • EE417 Budget Impact Analysis of Venetoclax Combination Therapies for the Treatment of Newly Diagnosed Acute Myeloid Leukemia Patients Who Are Aged 75 Years or Older, or Who Have Comorbidities That Preclude Use of Intensive Induction Chemoth ...

    Jul 1, 2025, 00:00

  • EE471 Patient Value Assessment Using a Unified Measure Based on Data Envelopment Analysis: A Case Study

    Jul 1, 2025, 00:00

  • EE233 Cost and Prevalence of Pre-Analytical Errors: A Narrative Review

    Jul 1, 2025, 00:00

  • EPH3 Assessing Prescribing Trends for Select Glucagon-Like Peptide Receptor Agonists (GLP-1s) by Patient Demographics, Providers, and Indication

    Jul 1, 2025, 00:00

  • PCR257 Real-World Evidence on Health-Related Quality of Life in Older Women With Advanced Breast Cancer Treated With CDK 4/6 Inhibitors

    Jul 1, 2025, 00:00

  • HPR149 Analysis of 20 Years of Legislative Trends to Predict Future Investment and Access to Orphan Drugs

    Jul 1, 2025, 00:00

  • CO39 Risk of Cutaneous Adverse Drug Reactions with GLP-1 Receptor Agonists: Insights from FAERS and Systematic Review

    Jul 1, 2025, 00:00

  • HSD6 The Impact of One-Day Surgery Performance Indicators on Hospital Capacities in Hungary

    Jul 1, 2025, 00:00

  • HPR136 From Data to Decisions: The Role of Real-World Evidence in Recent Multiple Myeloma Drug Approvals in the US and EU

    Jul 1, 2025, 00:00

  • HPR135 Learnings from State and Federal Drug Pricing Negotiations Across the United States: the Impact of Prescription Drug Affordability Boards

    Jul 1, 2025, 00:00

  • P43 IPDvariate: Reconstructing Patient Characteristics and Survival Data from Kaplan-Meier Curves for Subgroup Analysis

    Jul 1, 2025, 00:00

  • HSD7 Development of Hungarian One-Day Surgical Care in the Public-Funded National Healthcare System From 2010 to 2023

    Jul 1, 2025, 00:00

  • MSR32 Dual Inhibitor Identification for Mutated IDH1/2 To Reduce D-2-Hydroxyglutarate in Glioblastoma

    Jul 1, 2025, 00:00

  • PCR215 Self-Reported Health-Related Quality-of-Life in Adolescent Patients with Complex Chronic Health Conditions from A Longitudinal Registry Study in Los Angeles County

    Jul 1, 2025, 00:00

  • HPR49 Formulary Inclusion for Oncologic Indications: Comparing FDA-Approved Indications and Off-Label Compendia Support

    Jul 1, 2025, 00:00

  • PCR22 Differences in Demographic and Clinical Profiles Among Patients Adherent Vs. Non-Adherent to Revefenacin Following a COPD-Related Hospitalization

    Jul 1, 2025, 00:00

  • EE418 Cost-effectiveness of Esketamine versus Real-world Treatments for Patients with Treatment-resistant Depression: A Multi-armed Modelling Study

    Jul 1, 2025, 00:00

  • PCR3 Changes in Functional Status, Work Productivity, and Daily Activities in People With Idiopathic Hypersomnia and Narcolepsy Treated With Low-Sodium Oxybate: Results From the Phase 4 DUET Study

    Jul 1, 2025, 00:00

  • MSR23 Does Our Instrument Include the Right Response Options? Empirical Evidence to Evaluate Floor and Ceiling Effects for Multi-Item Ordinal Instruments

    Jul 1, 2025, 00:00

  • PCR125 Patients' Experiences With Prescription Opioid Use for Acute and/or Chronic Pain Management: A Qualitative Study

    Jul 1, 2025, 00:00

  • PCR158 Enhancing Patient Engagement in Pharmacist-Provided Medication Therapy Management for Chronic Conditions

    Jul 1, 2025, 00:00

  • EPH176 Depression Among Rheumatoid Arthritis Patients Using the Medical Expenditure Panel Survey Database

    Jul 1, 2025, 00:00

  • PCR111 Tracking Patterns in Sleep Disturbances During Flare-Ups in Patients With Atopic Dermatitis: Insights From an App-Based Digital Health Tracking Study

    Jul 1, 2025, 00:00

  • EPH140 Analysis of the Epidemiological Burden of Osteoarthritis in Hungary Based on Data From the Global Burden of Disease Study

    Jul 1, 2025, 00:00

  • EPH180 Trends of Mortality by Ulcer Decubitus in Colombia, 1998 - 2022

    Jul 1, 2025, 00:00

  • EE244 Economic Feasibility of 'Pay One Price': An Analysis of Three Biosimilar Molecules with Different Prices and Indicated for Rheumatoid Arthritis in a Medium Size HMO

    Jul 1, 2025, 00:00

  • PCR1 Health-Related Quality of Life Research in Jordan: A Systematic Review of Published Studies

    Jul 1, 2025, 00:00

  • EE492 Association Between Elevations in Alkaline Phosphatase and Healthcare Utilization and Costs Among Individuals With Primary Biliary Cholangitis In The United States

    Jul 1, 2025, 00:00

  • EE457 Real-World Study Evaluating Drug Tolerability and Health Care Resource Use (HCRU) With Acalabrutinib vs. Ibrutinib in Treatment-Naïve Patients With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

    Jul 1, 2025, 00:00

  • MSR50 Balancing Baseline Characteristics With SMOTE and Propensity Score Weighting in a Comparative Study of PASCAL Transcatheter Valve Repair and Medical Therapy for Degenerative Mitral Regurgitation

    Jul 1, 2025, 00:00

  • RWD161 The Contribution of Lab Results Data Linked to Claims Data in Identifying Chronic Kidney Disease Staging

    Jul 1, 2025, 00:00

  • CO64 Discordance Between Apolipoprotein B (apoB) and LDL-Cholesterol (LDL-C) and Incident Hypertension Risk among Patients with and without Type 2 Diabetes (T2D): An Analysis of US Real-World Data

    Jul 1, 2025, 00:00

  • MT5 Real-Time Technology Adoption: Assessing Early Real-World Trends in Renal Denervation Therapy Following Initial Device Approval

    Jul 1, 2025, 00:00

  • EE298 Optimized Treatment Sequences for ALK+ Stage IV NSCLC: Cost-Effectiveness Analysis From RCT data and Real-World Evidence

    Jul 1, 2025, 00:00

  • PCR10 Discontinuation Rates of Once-Weekly GLP-1 Receptor Agonists (GLP-1 RAs) in Patients With Type 2 Diabetes

    Jul 1, 2025, 00:00

  • HPR85 The Duration of Medically Necessary Drug Shortages

    Jul 1, 2025, 00:00

  • EE379 Economic and Environmental Impact of Decentralized Cancer Care (DCC) in Oncology: An Innovative Experience in the French Alps

    Jul 1, 2025, 00:00

  • RWD88 Real World Treatment Patterns, Genetic Testing, and Clinical Outcomes among Patients with mCRPC Treated with Olaparib Monotherapy in US Urology Clinics

    Jul 1, 2025, 00:00

  • EPH68 Mortality trends in Centenarians in Colombia, 2008 - 2022

    Jul 1, 2025, 00:00

  • EE239 Value of Liquid Biopsy for Genomic Profiling in Non-Small Cell Lung Cancer in Fran A Pharmacoeconomic Model

    Jul 1, 2025, 00:00

  • RWD146 The Cost Burden of Infertility Therapy for Women with a History of Hysteroscopic Adhesiolysis Compared to Those with Other or no Previous Intrauterine Surgery

    Jul 1, 2025, 00:00

  • MSR34 Development of a Novel Approach to Improve Binary Classification Prediction Tasks When Encountering Time-To-Event Data: Performance Comparison of Three Alternative Approaches To Predict Stimulant Use Disorder Among Persons Authorized ...

    Jul 1, 2025, 00:00

  • MSR133 A Comprehensive Review of Real-World Evidence (RWE) Use in Submissions to Canada's Drug Agency (CDA)

    Jul 1, 2025, 00:00

  • MSR137 A Statistical Method for Quality Assessment of Demographic Variables in EHR Data

    Jul 1, 2025, 00:00

  • CO2 Differential Effect of Transdiagnostic Cognitive-Behaviour Therapy on Health-Related Quality of Life According to the Number of Anxiety Comorbidities

    Jul 1, 2025, 00:00

  • HTA56 A Targeted Review of the Application of Discrete Event Simulation Modeling in CDA-AMC Assessments

    Jul 1, 2025, 00:00

  • P25 HELMET: A Benchmark Dataset for Evaluating Generative AI in Health Economics and Outcomes Research

    Jul 1, 2025, 00:00

  • RWD136 Integration of Survival Analysis Outputs Into Excel-Based Cost-Effectiveness Models Using Generative AI

    Jul 1, 2025, 00:00

  • MT30 Clinical and Economic Outcomes of Ultrasonic Energy Devices Used in Patients Treated With Sleeve Gastrectomy

    Jul 1, 2025, 00:00

  • EE422 Integrating Metrics of Environmental Sustainability into Economic Evaluations: A Targeted Literature Review

    Jul 1, 2025, 00:00

  • MSR92 The Importance of Specifying the Estimand in Meta-Analyses in the Presence of Treatment Switching

    Jul 1, 2025, 00:00

  • PCR223 Lifestyle Habits of Patients with Prediabetes Before and After Diagnosis

    Jul 1, 2025, 00:00

  • EE205 Impact of Polatuzumab Vedotin as First-Line Therapy for DLBCL on Subsequent Treatments: Brazilian Model

    Jul 1, 2025, 00:00

  • MSR132 Association Between Initiation of ENDS and Cigarette Smoking Reduction: A Causal Time Zero Approach to the PATH Study

    Jul 1, 2025, 00:00

  • HPR24 Moving the Needle: Value and Use of Real-World Evidence in Oncology Clinical Pathways Decision-Making

    Jul 1, 2025, 00:00

  • PCR212 Development and Psychometric Validation of Patient-Reported Outcome Measures for Masseter Muscle Prominence (MMP): The Lower Facial Shape Questionnaire

    Jul 1, 2025, 00:00

  • MSR13 TransportHealth: A Novel, Flexible, Open-Source R Package for Transportability and Generalizability Analysis

    Jul 1, 2025, 00:00

  • PCR33 Development of New Patient Reported Outcome (PRO) Conceptual Models for Treatment Adherence and Satisfaction in People with HIV

    Jul 1, 2025, 00:00

  • PCR236 Examining The Association Of Self-Reported Condition Severity And Excessive Daytime Sleepiness Severity With Health-Related Outcomes Among Individuals With Narcolepsy In The United States

    Jul 1, 2025, 00:00

  • EPH53 Analysis of the Contribution of Air Pollution and Noise Levels to Predicting Autonomic Nervous System Disorders: An Interpretable Machine Learning Approach

    Jul 1, 2025, 00:00

  • EE375 Real-World Adherence, Healthcare Resource Utilization, And Costs Among Patients With Schizophrenia Utilizing Once-Monthly, Once-Every-Three-Months, And Once-Every-Six-Months Paliperidone Palmitate in the United States

    Jul 1, 2025, 00:00

  • CO32 Socioeconomic Status and Anti-obesity Medications: Impact on Cardiovascular Risk in Medicare Patients with Obesity

    Jul 1, 2025, 00:00

  • EE214 Cost-Utility Analysis of Faricimab Versus Aflibercept in Treating Neovascular Age-Related Macular Degeneration (nAMD) in the United States

    Jul 1, 2025, 00:00

  • HTA45 Analysis of NICE Assessments for Orphan Treatments and Key Drivers for Decision-Making

    Jul 1, 2025, 00:00

  • HPR141 Analysis of Patient Pathway on In Vitro Fertilization Treatment in Hungary

    Jul 1, 2025, 00:00

  • RWD41 Shifting Landscapes: Rising Trends in Breast and Colon Cancer Screenings and Diagnoses

    Jul 1, 2025, 00:00

  • HSD80 Assessing Real-World Dosing Patterns for Vesicular Monoamine Transporter-2 Inhibitors (VMAT2i), Valbenazine and Deutetrabenazine, Among Patients with Tardive Dyskinesia (TD) in a Nationwide US Claims Database

    Jul 1, 2025, 00:00

  • EE361 Treatment Patterns and Efficacy/Safety of the Drugs in HER2+ NSCLC: A Systemic Literature Review

    Jul 1, 2025, 00:00

  • RWD113 Impact of NGS Testing Timing on Real-World Treatment Patterns and Clinical Outcomes in Colorectal Cancer: A Retrospective Observational Study

    Jul 1, 2025, 00:00

  • HSD81 A Real-World Perspective of Quadruple Treatment Patterns for 1L Multiple Myeloma Patients across North and South America, Europe and Asia

    Jul 1, 2025, 00:00

  • MSR5 Translation, Cross-Cultural Adaptation and Psychometric Evaluation of the Yoruba Version of Musculoskeletal Health Questionnaire

    Jul 1, 2025, 00:00

  • RWD57 Linkage of Clinical Trial Data to Real-World Data (RWD) Sources: A Scoping Review

    Jul 1, 2025, 00:00

  • MT25 Modeling Challenges and Critiques in Economic Evaluations of Medical Devices: A Review of NICE Medical Technologies Guidance

    Jul 1, 2025, 00:00

  • MSR24 Leveraging Machine Learning to Assess the Association of Rash and Survival in Patients With Advanced NSCLC

    Jul 1, 2025, 00:00

  • MSR105 Stability of a Large Language Model for Data Extraction in Systematic Literature Reviews

    Jul 1, 2025, 00:00

  • EPH170 Administrative Frequency of Vitiligo and Clinical Characteristics in a Colombian HMO: A Real World Data Characterization From 2015 to 2023

    Jul 1, 2025, 00:00

  • EPH66 Antidiabetic Medication Uses Among Pregnant Women: Real-World Prescription Pattern in South Korea

    Jul 1, 2025, 00:00

  • EPH45 Evaluating the National and Regional Prevalence and Incidence Rates of Hepatitis Delta Virus Among Patients With Hepatitis B Virus Infection in Italy

    Jul 1, 2025, 00:00

  • EPH11 Adverse Events Associated With Recently Approved Alzheimer's Drugs: A Real-World Pharmacovigilance Study

    Jul 1, 2025, 00:00

  • EPH165 Race, Social Determinants of Health (SDoH), and Stage at Breast Cancer Diagnosis in Electronic Health Records (EHR) Data

    Jul 1, 2025, 00:00

  • HSD32 Innovative Strategy for Resistant Depression and Suicidal Ideation: HEOR Analysis From the Perspective of BRAZIL / LATAM / LMIC

    Jul 1, 2025, 00:00

  • P38 Cost-Effectiveness of Belimumab for the Treatment of Adults With Active Lupus Nephritis in Canada

    Jul 1, 2025, 00:00

  • RWD119 Identification and mapping of Real-World Data Sources for Giant Cell Arteritis (GCA) and Polymyalgia Rheumatica (PMR)

    Jul 1, 2025, 00:00

  • PCR242 The Economic Burden of Narcolepsy in the United States: Matched Analysis of National Health and Wellness Survey Data

    Jul 1, 2025, 00:00

  • EPH179 Associations Between Post-Diagnostic Statin Use, Cholesterol Levels, and Mortality Risk Among American Breast Cancer Patients: Insights from the National Health and Nutrition (NHANES) Survey

    Jul 1, 2025, 00:00

  • PCR77 Development of a Conceptual Model of the Patient Experience with Idiopathic Hypersomnia: Patient Interviews from a Clinical Trial (NCT05156047)

    Jul 1, 2025, 00:00

  • EE475 Description and Healthcare Resource Utilization of Patients With Moderate or Severe Lupus Using US Insurance Claims

    Jul 1, 2025, 00:00

  • EE423 Treatment Patterns, Clinical Outcomes, Healthcare Resource Utilization, and Healthcare Costs Among Patients With Metastatic Gastric/Gastroesophageal Junction Cancer in Medicare Beneficiaries

    Jul 1, 2025, 00:00

  • P51 How Can We Make Innovative Payment and Pricing Schemes Work? Findings of the European Union Research Project HI-PRIX

    Jul 1, 2025, 00:00

  • MSR26 Sentence-Level Abstract Section Classification in HEOR Literature using a Biomedical Language Model

    Jul 1, 2025, 00:00

  • EPH57 Administrative Incidence and Prevalence of Multiple Myeloma Using Administrative Claims Data From a Large Health Maintenance Organization in Colombia, 2015–2023

    Jul 1, 2025, 00:00

  • EPH46 Evaluation of Epidemiological Disease Burden of Endometriosis Based on Routinely Collected Health Data Between 2010 and 2019

    Jul 1, 2025, 00:00

  • HSD3 Gaps In Screening Among Medicare Patients With A Ruptured Abdominal Aortic Aneurysm

    Jul 1, 2025, 00:00

  • RWD138 Predictor of dispensing behavior for mental health treatments in Saudi Arabia

    Jul 1, 2025, 00:00

  • MSR106 Breaking Linguistic Barriers: Cross-Language HEOR Evidence Integration Through GenAI

    Jul 1, 2025, 00:00

  • EPH169 Contemporary Treatment Patterns of Patients with Muscle-Invasive Bladder Cancer Undergoing Radical Cystectomy: A Retrospective Analysis of German Claims Data

    Jul 1, 2025, 00:00

  • HSD21 A Qualitative Assessment of Emergency Physician Perceptions and Experiences with Acute Pain Management

    Jul 1, 2025, 00:00

  • EE278 A Systematic Scoping Review of Published Economic Analyses of Public Cord Blood Banking: Is It Time to Re-Assess?

    Jul 1, 2025, 00:00

  • EPH128 Changes in the Prevalence of Pregnancy Complications During the COVID-19 Pandemic: Is Increased Prevalence the New Normal?

    Jul 1, 2025, 00:00

  • HTA91 Advancing Equitable Access to Cystic Fibrosis Treatment in Brazil: Strategies for Implementing National Clinical Guidelines

    Jul 1, 2025, 00:00

  • PCR249 Impact of Cardiovascular, Renal and Metabolic Comorbidities on Activity and Health-Related Quality of Life in Patients with Metabolic Dysfunction-Associated Steatohepatitis in France, Italy, Germany, and Canada

    Jul 1, 2025, 00:00

  • HSD109 Hospital-Level Effects on Cardiovascular Monitoring Among Cancer Patients Treated with Cardio-Toxic Therapies

    Jul 1, 2025, 00:00

  • PCR39 Patient-Centered Research (Patient-Reported Outcomes and Quality of Life Outcomes)

    Jul 1, 2025, 00:00

  • MSR107 MetaSLR in Automating the Data Collection for Systematic Literature Reviews

    Jul 1, 2025, 00:00

  • EPH98 Prevalence of Diabetes and Its Impact on Hospitalization among Patients with Cancer: A Population-Based Study in the U.S

    Jul 1, 2025, 00:00

  • P39 Cost-Effectiveness of Transthyretin Stabilizing Agents for the Treatment of Transthyretin Amyloid Cardiomyopathy (ATTR-CM)

    Jul 1, 2025, 00:00

  • EPH93 Protocol for a Real-World Retrospective Study on Cardiovascular Outcomes in Japan Comparing Heated Tobacco Product Users, Cigarette Smokers, Former Smokers, and Never Smokers

    Jul 1, 2025, 00:00

  • RWD52 Treatment Patterns for Sleep Disorders in the United States Veterans Affairs Healthcare System

    Jul 1, 2025, 00:00

  • HPR58 Exploring Contemporary Variability in PDMP Budgets and Data Sharing Across the United States

    Jul 1, 2025, 00:00

  • EE461 Costs And Healthcare Resource Utilization In Patients With Transthyretin Amyloid Cardiomyopathy: A Systematic Literature Review

    Jul 1, 2025, 00:00

  • OP11 Audience and Publication Profiles in HEOR Research: A Cross-Sectional Analysis of Non-Small-Cell Lung Cancer and Coronary Artery Disease Studies in 2024

    Jul 1, 2025, 00:00

  • PT25 The Impact of Financial Assistance Programs on Medication Adheren A Systematic Review With AI-Driven Prediction

    Jul 1, 2025, 00:00

  • HSD91 Development of an Online Patient Decision Aid and Culturally Conscious Toolkit for Inflammatory Bowel Disease

    Jul 1, 2025, 00:00

  • RWD109 Trends in the Global Drug Development Pipeline 2024

    Jul 1, 2025, 00:00

  • HSD31 Identification of Barriers to and Practical Strategies for Increasing Clinical Trial Diversity: A Scoping Review

    Jul 1, 2025, 00:00

  • EE419 Cost-Effectiveness Analysis of Bivalent Respiratory Syncytial Virus Prefusion F Vaccine for Adults 60 Years of Age and Older in Japan

    Jul 1, 2025, 00:00

  • PCR41 Exploring the Landscape of Patient-Reported Outcomes in PCOS Clinical Trials

    Jul 1, 2025, 00:00

  • CO58 Progression-Free Survival and Objective Response Rates As Surrogate Endpoints for Overall Survival Among Patients With ROS1+ Locally Advanced or Metastatic Non-Small Cell Lung Cancer Receiving ROS1 Tyrosine Kinase Inhibitors

    Jul 1, 2025, 00:00

  • P37 Trial-Based Economic Evaluation of the BrainACT Study: Acceptance and Commitment Therapy for Anxiety and/or Depressive Symptoms After Acquired Brain Injury in the Netherlands

    Jul 1, 2025, 00:00

  • RWD65 Real-World Treatment Patterns, Patient Characteristics, Healthcare Resource Utilization and Costs for Intermediate Hepatocellular Carcinoma Patients in Canada: A Retrospective Cohort Study Using Provincial Administrative Data

    Jul 1, 2025, 00:00

  • EPH41 Use of Artificial Intelligence for Rapid Epidemiology Reviews With Pooled Prevalence and Incidence Estimates

    Jul 1, 2025, 00:00

  • EPH146 Pre-Diagnostic Healthcare for People with Fragile X Syndrome

    Jul 1, 2025, 00:00

  • P20 The Past, Present, and Future of Demand for Bariatric Surgery in Chile: A Subgroup Analysis for no-income (Group A) FONASA Beneficiaries

    Jul 1, 2025, 00:00

  • EPH17 Time to Diagnosis of Lung Cancer From Identification of a Pulmonary Nodule in the United States

    Jul 1, 2025, 00:00

  • MSR157 Analytical Approaches to Estimate Medication Persistence From Electronic Health Record Data: A Study of Tyrosine Kinase Inhibitors in Patients With Epidermal Growth Factor Receptor-Positive Advanced Non-Small Cell Lung Cancer

    Jul 1, 2025, 00:00

  • EPH91 Conceptual Mapping of Health-Related Quality of Life, Quality of Life, and Wellbeing: A Systematic Review and Assessment of Commonly Used Patient Reported Outcomes Measures

    Jul 1, 2025, 00:00

  • CO10 A Real-World Retrospective Cohort Study Characterizing Patients with MMN in the United States

    Jul 1, 2025, 00:00

  • PCR185 Associations Between Social Vulnerability and Long COVID: A Nationwide U.S. Study Among Symptomatic Outpatient

    Jul 1, 2025, 00:00

  • HPR88 Factors Affecting Per Capita Costs in Subdistrict Health Promotion Hospitals (SHPH) After Transfer to Provincial Administrative Organizations (PAO): A Study of Allocation Models in Thailand

    Jul 1, 2025, 00:00

  • PCR160 Real-World Evidence of Setmelanotide in Patients with Rare Melanocortin-4 Receptor Pathway Diseases: Baseline Findings from the RESTORE Longitudinal Survey Study

    Jul 1, 2025, 00:00

  • HPR12 Exploring the Equity of Out-of-Pocket Healthcare Expenses and Catastrophic Healthcare Expenditures in Taiwanese Households

    Jul 1, 2025, 00:00

  • HTA77 How to Best Model Caregiver Quality of Life in Health Technology Assessments? Lessons from NICE Submissions in Multiple Sclerosis

    Jul 1, 2025, 00:00

  • HSD93 Real-World Peripheral Embolization Characteristics Among Medicare Patients

    Jul 1, 2025, 00:00

  • EPH174 Sociodemographic Determinants and Inequities in Prenatal Healthcare in the Canadian Province of Manitoba: A Population-Based Cohort Study 2010-2022

    Jul 1, 2025, 00:00

  • MSR129 Healthcare Resource Utilization Disruptions During the COVID-19 Era and Methodological Considerations: A Review

    Jul 1, 2025, 00:00

  • EE387 Durability and Cost-Minimization of Reprocessed Surgical Drills

    Jul 1, 2025, 00:00

  • HTA16 AMCP Dossier v5.0: U.S. Payer Preferences and Utilization to Support Formulary Decision Making

    Jul 1, 2025, 00:00

  • RWD97 Real-World Treatment Patterns of Metastatic EGFR-Mutated Non-Small Cell Lung Cancer (NSCLC) Patients from the Integra Connect Database

    Jul 1, 2025, 00:00

  • MSR57 Extended MAIC to Validate Results in Cases of Poor Population Overlap: An Application to Compare Prophylactic Treatments in Pediatric Patients With Hemophilia A

    Jul 1, 2025, 00:00

  • RWD8 Variability in Definitions and Measurement Approaches of Vaso-Occlusive Crises (VOCs) in Sickle Cell Disease (SCD): A Targeted Literature Review of Global Real-World Evidence (RWE) Studies

    Jul 1, 2025, 00:00

  • PCR199 Measuring Patient Engagement: The Importance of a Framework

    Jul 1, 2025, 00:00

  • PT31 Psychometric Testing of the ICECAP-A in Patients With Coeliac Disease: A Comparative Analysis With EQ-5D-5L

    Jul 1, 2025, 00:00

  • EE381 Estimating the U.S. Economic Burden of Autoimmune Diseases: A Pilot Systematic Literature Review

    Jul 1, 2025, 00:00

  • HPR77 Analysis of Real-World Evidence Use Across FDA Submissions in 2022 and 2023

    Jul 1, 2025, 00:00

  • CO86 Comparing Chemotherapy, Monotherapy, and Combination Immune Checkpoint Inhibitors for Non-Small-Cell Lung Cancer Progression-Free Survival and Overall Survival: Systematic Review and Meta-Analysis

    Jul 1, 2025, 00:00

  • MSR123 Standardized Tools for Constructing DAGs - Advancing Causal Inference and Risk Assessment in Pharmaceutical Studies

    Jul 1, 2025, 00:00

  • PCR217 How Disease Modifying Therapy Utilization In Multiple Sclerosis Is Influenced by Insurance and Out-Of-Pocket Cost in US Adults: A Summary Of Recent Literature

    Jul 1, 2025, 00:00

  • PCR192 From Short-Term Relief to Long-Term Benefits: Tracking the Impact of Insulin Pumps on Fear of Hypoglycemia in people with Type 1 Diabetes Mellitus

    Jul 1, 2025, 00:00

  • MSR98 AI-Enhanced Literature Review: Comparing Advanced Pancreatic Cancer Trial Outcomes According to Performance Status

    Jul 1, 2025, 00:00

  • MSR31 Using Artificial Intelligence to Predict Patient's Preferences

    Jul 1, 2025, 00:00

  • HTA34 Assessability of Single-Arm Studies (SAT) Under Joint Clinical Assessment (JCA): Whether Drugs Assessed With SAT in the Last Years Would Fit Under the New EU HTA Framework?

    Jul 1, 2025, 00:00

  • MSR154 An Illustration of the Impact of Confounding Bias On Economic Evaluations in the Context of Real-World Evaluations

    Jul 1, 2025, 00:00

  • EE358 Validation of a Flexible Partitioned Survival and 3-State Markov Model for Cost-Effectiveness Analyses in Oncology

    Jul 1, 2025, 00:00

  • MSR9 Using Autonomous Generative AI Agents for Data Extraction from Clinical Study Reports: Accuracy Assessment Against Canada's Drug Agency Reports

    Jul 1, 2025, 00:00

  • RWD31 The Role of Real-World Evidence in Breast Cancer Drug Submissions to NICE: Insights and Challenges

    Jul 1, 2025, 00:00

  • HPR41 Are Patients With Major Depressive Disorder (MDD) Getting Access to Innovation in HTA Markets? Review of Reimbursement Decisions of Pharmacotherapies for MDD in Europe, Australia, and Canada From 2001 to 2021

    Jul 1, 2025, 00:00

  • CO82 Comparative Effectiveness and Safety of Factor Xa Inhibitors in Atrial Fibrillation: A Systematic Literature Review of Real-World Evidence in Europe

    Jul 1, 2025, 00:00

  • HPR55 Assessing the Impact of the United States (US) Inflation Reduction Act (IRA) Regulations on Investment Incentives for Orphan Disease Drug Development

    Jul 1, 2025, 00:00

  • PCR141 Estimating the HRQoL Shortfall of Long COVID: Meta Analysis of Cohort Studies Relative to Population Norms

    Jul 1, 2025, 00:00

  • SA9 Methodological Approaches and Current Applications of Distributed Cost-Effectiveness Analysis: A Systematic Review

    Jul 1, 2025, 00:00

  • HTA57 Impact of China's NRDL Value-Rating System on Reimbursement and Pricing of Innovative Therapies

    Jul 1, 2025, 00:00

  • EE484 A Return On Investment Evaluation Of An Antibiotic Audit And Feedback Program Among Family Physicians

    Jul 1, 2025, 00:00

  • RWD28 Hospitalization for Respiratory Tract Infections Increase the Use of Medical Care and Long-Term Care Services: A Pre-Post Assessment Adopting Difference-in-Differences Analysis on LIFE Study Data

    Jul 1, 2025, 00:00

  • HPR59 Access Disparities in Maintenance Medication among Patients with Mild Asthma

    Jul 1, 2025, 00:00

  • HTA51 Broadening the Scope of Value: Evaluating Payer Perspectives and Insights on ICER's Latest Initiatives and Tools

    Jul 1, 2025, 00:00

  • HTA65 An Overview of Pricing and Reimbursement Frameworks for Medicinal Products in Central and Eastern European (CEE) Countries: Mechanisms, Rules, And Managed Entry Agreements (MEAs)

    Jul 1, 2025, 00:00

  • MSR25 NMCP Delayed Time to Hospital Encounter and Reduced Cost compared to OMCP in Patients with Gastroparesis - A Real World Study

    Jul 1, 2025, 00:00

  • RWD76 Real-World Treatment Patterns Among Patients With Scalp Psoriasis in Canada

    Jul 1, 2025, 00:00

  • EPH160 Prevalence of Mental Health Conditions Among Individuals With Sickle Cell Disease in Texas Medicaid

    Jul 1, 2025, 00:00

  • PCR46 The Association Between COVID-19 Vaccination and Health-Related Quality of Life and Work Productivity: A Systematic Literature Review

    Jul 1, 2025, 00:00

  • P16 The Impact of Hallucinations in Synthetic Health Data on Prognostic Machine Learning Models

    Jul 1, 2025, 00:00

  • PCR235 Quality of Life Assessment of Patients Undergoing Hip Replacement Surgery in the Public and Private Healthcare Systems

    Jul 1, 2025, 00:00

  • EE325 A Systematic Literature Review of the Economic Burden in Patients with Ehlers-Danlos Syndrome in the United States

    Jul 1, 2025, 00:00

  • EPH127 Assessment of Racial Disparities in Prenatal Flu Vaccination in the United States

    Jul 1, 2025, 00:00

  • PCR173 Psychometric Evaluation of the Mastocytosis Symptom Severity Daily Diary (MS2D2) Instrument in Patients with Nonadvanced Systemic Mastocytosis (NonAdvSM)

    Jul 1, 2025, 00:00

  • PCR48 An Overview of the Patient Journey and Treatment Utilization in Patients With Prurigo Nodularis

    Jul 1, 2025, 00:00

  • PCR103 Attitude, Knowledge, and Intention to Receive Shingles Vaccine Using the Theory of Planned Behavior in Saudi Arabia

    Jul 1, 2025, 00:00

  • MSR20 Discordance Between Two Claims-Based Frailty Indices in a Hospitalized Medicare Population

    Jul 1, 2025, 00:00

  • HTA86 Focus Group Evaluation of Criteria for the Value Assessment of Medication-Adherence Enhancing Interventions (MAEIs)

    Jul 1, 2025, 00:00

  • Stakeholder Views on the Use and Challenges of Using Early Economic Evaluations in Health Innovation Development in The Netherlands

    Jul 1, 2025, 00:00

  • EPH192 The Trajectory of Ground Glass Nodule Patients in China: A Real-World Perspective

    Jul 1, 2025, 00:00

  • RWD20 Real-World Effectiveness of Biologic Treatments for Moderate-to-Severe Plaque Psoriasis in Poland in Comparison With Efficacy Reported in Clinical Trials

    Jul 1, 2025, 00:00

  • HPR111 Assessing Stakeholder Perceptions of Product Portfolio Value Beyond Financial Benefit: Development of a Survey

    Jul 1, 2025, 00:00

  • EPH189 A Retrospective Claims Study Characterizing the Association Between RSV Infection and Acute Otitis Media and Related Burden in Infants and Young Children = 5 years in Japan

    Jul 1, 2025, 00:00

  • MSR6 Staffing Resource Use: A Cost Impact Model for the Utilization and Implementation of Medications for Opioid Use Disorder Within US Jails And Prisons

    Jul 1, 2025, 00:00

  • MSR72 Integrating Artificial Intelligence (AI) and Machine Learning (ML) Techniques With Real-World Data (RWD) and Real-World Evidence (RWE) to Inform Precision Medicine: A Scoping Review

    Jul 1, 2025, 00:00

  • EPH90 The Potential Clinical Impact of the Moderna Next-Generation COVID-19 mRNA-1283 Vaccine in United States (US) Adults

    Jul 1, 2025, 00:00

  • PCR58 Mapping the HAQ-DI to the EQ-5D-5L and SF-6Dv2 Among Chinese Patients With Gout

    Jul 1, 2025, 00:00

  • RWD147 The Role of Social Determinants of Health (SDoH) Data in Improving Risk Predictions

    Jul 1, 2025, 00:00

  • HSD4 Aggressive End-of-Life Care among Non-Small Cell Lung Cancer Medicare Patients

    Jul 1, 2025, 00:00

  • EE456 The Cost of Complications In Graft Repair For Extremity Arterial Trauma: Real-World Evidence From Linked Hospital Chargemaster And Insurance Claims Databases

    Jul 1, 2025, 00:00

  • HPR166 Improving the Healthcare System Through Health Technology Assessment: A Case Study of Nepal

    Jul 1, 2025, 00:00

  • CO52 Glucocorticoid Exposure and the Risk of Serious Infections in CIDP

    Jul 1, 2025, 00:00

  • EPH112 Frequency of Gram-Negative Bacteria at the Military Medical Center in Guatemala

    Jul 1, 2025, 00:00

  • HSD43 Addressing Neighborhood-Level Opioid Data Gaps: Development of an Interactive Dashboard for Prescription Trends and Buprenorphine Access in California

    Jul 1, 2025, 00:00

  • HPR130 Patient Journey Mapping for Common Illness Care Services at Community Pharmacies

    Jul 1, 2025, 00:00

  • MSR52 Tailoring Generalized Cost-Effectiveness Analysis (GCEA) to the U.S. Setting: the Importance of Using the Right Prices

    Jul 1, 2025, 00:00

  • HSD83 Identifying Drivers for the Timely Referral of Patients for a Rare Disease Diagnosis: A Cross-Sectional Survey of Physicians in the United States

    Jul 1, 2025, 00:00

  • EE362 Drug Pricing Differentials Across Therapy Areas in EU4, UK, and US

    Jul 1, 2025, 00:00

  • P44 Predicting Overall Survival (OS) from Time to Recurrence (TTR) Using a Copula-Based Patient-Level Surrogacy Model with Parametric Marginal Survival Distributions: Application to Adjuvant Treatment of Patients with Colon Cancer

    Jul 1, 2025, 00:00

  • CO13 Dupilumab Improves Health-Related Quality of Life in Patients With Chronic Obstructive Pulmonary Disease and Type 2 Inflammation: Results From the BOREAS and NOTUS Trials

    Jul 1, 2025, 00:00

  • HTA49 Practical Application of the ICER-developed Clinical Trial Diversity Rating Tool

    Jul 1, 2025, 00:00

  • EPH72 Pattern of Opioid Prescriptions Among Patients With Breast, Lung, and Colorectal Cancer Diagnosed With Chronic Non-Malignant Pain

    Jul 1, 2025, 00:00

  • HSD42 Exploring physicians' Perspectives on the Diagnosis Journey of Rare Diseases in the United States (US): Findings from a Cross Sectional Survey

    Jul 1, 2025, 00:00

  • HSD14 Colorectal Cancer Screening Initiation Modalities Among Newly Age-Eligible Medicaid-Insured Individuals in Texas

    Jul 1, 2025, 00:00

  • HPR164 Pediatric Opioid Prescribing Patterns: Analyzing Trajectories Using Texas PDMP Data in the Context of AAP Guidelines

    Jul 1, 2025, 00:00

  • PCR172 Knowledge and Willingness to Self-Sampling About Cervical Cancer Screening in Zala County, Hungary

    Jul 1, 2025, 00:00

  • PCR252 Mapping the ADDQoL to the EQ-5D-5L and SF-6Dv2 among Chinese Patients with Type 2 Diabetes Mellitus

    Jul 1, 2025, 00:00

  • HPR60 What Proportion of the Total Value Generated by New Drugs Accrues to Manufacturers? A Review of Empirical Estimates of Producer Surplus

    Jul 1, 2025, 00:00

  • EPH50 Disparities in Access to COPD Medications in Brazil - Impact of Geography and Socioeconomic Factors on Patient Travel Distances

    Jul 1, 2025, 00:00

  • EE444 Economic Analysis of the Use of Polyhexamethylene Biguanide Associated with Betaine (PHMB) Gel Compared to Silver Sulfadiazine in the Treatment of Second-Degree Burns

    Jul 1, 2025, 00:00

  • EE488 The Economic Benefit of Biosimilars in North America: A Targeted Literature Review

    Jul 1, 2025, 00:00

  • MSR134 A Web-Based Application To Automate the Development of State-Transition Models in Oncology Using Published Survival Curves and Bayesian Calibration

    Jul 1, 2025, 00:00

  • EE527 Therapeutic Options for Changing the Course of Disease in Generalized Myasthenia Gravis (gMG) and Fiscal Consequences for the Canadian Governments

    Jul 1, 2025, 00:00

  • EE308 Incidence of Opioid Use Disorder and the Associated Economic Burden Among People Managing Acute Pain With Prescription Opioids in the United States in Commercial, Medicare, and Medicaid Populations

    Jul 1, 2025, 00:00

  • EPH6 Cost and Use of Medical Devices in Incident Early-Onset Myasthenia Gravis Patients in France

    Jul 1, 2025, 00:00

  • RWD59 Uptake of national guidance for prescribing of SGLT-2 inhibitors for type 2 diabetes in the UK

    Jul 1, 2025, 00:00

  • HPR123 Socioeconomic Vulnerabilities and Postpartum Depression: Assessingthe Aftermath of Dobbs v. Jackson in Trigger and Non-Trigger States

    Jul 1, 2025, 00:00

  • EE268 Cost-Effectiveness Analysis of Mirvetuximab Soravtansine in FRa-Positive Platinum-Resistant Ovarian Cancer in Japan

    Jul 1, 2025, 00:00

  • HPR35 Disparities in Testing for Mismatch Repair Genes Among Medicare Beneficiaries with Colon Cancer: A Claims-Based Analysis

    Jul 1, 2025, 00:00

  • MSR59 An Open-Source R-Shiny Application Designed to Perform Frequentist and Bayesian Mixed Model Repeated Measures (MMRM)

    Jul 1, 2025, 00:00

  • RWD87 How Well Does Hospital Billing Data Estimate Readmissions and Revision Risks After Spinal Fusion Surgery, Compared to Hospital Billing Linked to Claims Data?

    Jul 1, 2025, 00:00

  • EE495 Economic Impact of Experiential Negative Symptoms Among Patients Living With Schizophrenia: Medical Expenditure Panel Survey

    Jul 1, 2025, 00:00

  • PCR42 Measuring Patient- and Carer-Reported Outcomes Following Genome Sequencing for Rare Disease Diagnosis: A Psychometric Assessment of Outcome Measurement Instruments

    Jul 1, 2025, 00:00

  • RWD159 Burden of Illness in US Patients With Liver Cancer and Kidney Disease: A Real-World Claims Analysis

    Jul 1, 2025, 00:00

  • PCR208 Hematologist-Oncologist Preferences for Treating Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL) using Tyrosine Kinase Inhibitors in Combination with Chemotherapy: A Discrete Choice Experiment

    Jul 1, 2025, 00:00

  • PCR238 Development of a Conceptual Model Supporting a Clinical Outcome Assessment Strategy for Acquired Angioedema Due to C1 Inhibitor Deficiency

    Jul 1, 2025, 00:00

  • EE388 Computer-Assisted Fluoroscopic Navigation Is Cost Effective Compared To Robotic-Assisted And Manual Surgery In Total Hip Arthroplasty

    Jul 1, 2025, 00:00

  • EE315 Real-World Disease Management Costs for U.S. Patients With Muscle Invasive Bladder Cancer (MIBC) Following Radical Cystectomy (RC) in Contemporary Practice

    Jul 1, 2025, 00:00

  • MT20 A Bibliometric Analysis to Estimate the Reach and Impact of the Peterson Health Technology Institute's Digital Health Value Assessments

    Jul 1, 2025, 00:00

  • CO26 A Systematic Review and Meta-Analysis of da Vinci Robotic-Assisted Surgery vs. Laparoscopic or Open Approaches for Benign Colon Conditions

    Jul 1, 2025, 00:00

  • P13 Leveraging Real-World Data and NLP to Identify At Risk Metabolic Dysfunction Associated Steatohepatitis in the General Population

    Jul 1, 2025, 00:00

  • MSR37 Improve Analyst Accuracy in Systematic Literature Reviews Using Reliant Tabular and LLM-Based Relevance Scoring

    Jul 1, 2025, 00:00

  • HTA20 Drivers of High ICERs in SMC Appraisals

    Jul 1, 2025, 00:00

  • HPR132 Characterizing Post-Pandemic Social Determinants of Health of the Population Testing for COVID-19 in a Nationwide Network in the United States

    Jul 1, 2025, 00:00

  • HTA52 Too Many PICOS for Joint Clinical Assessments (JCA)? How To Adapt The Systematic Literature Reviews for Achieving Desired Outcomes

    Jul 1, 2025, 00:00

  • MT33 A Systematic Literature Review and Meta-Analysis of Clinical Outcomes Across Five Malignant Procedures for Robotic-Assisted Surgery with the Da Vinci Single Port Surgical System

    Jul 1, 2025, 00:00

  • EE452 Evaluating the Cost-Benefit of Automated Dispensing Cabinets in Long-Term Care and Closed-Door Pharmacies

    Jul 1, 2025, 00:00

  • CO6 Comparative Efficacy and Safety of Adjunctive CT-152 in Major Depressive Disorder: A Frequentist Network Meta-Analysis

    Jul 1, 2025, 00:00

  • HTA95 Mind The Gap: Delays Between Vaccine Licensure And NITAG Recommendation In The US Versus Europe

    Jul 1, 2025, 00:00

  • EE257 Cost-Effectiveness of Sotagliflozin for Patients With Type 1 Diabetes and Chronic Kidney Disease, With and Without Dynamic Pricing

    Jul 1, 2025, 00:00

  • HTA53 The Dynamic Nature of Network Meta-Analysis: How Data Updates Could Influence Health Technology Assessment

    Jul 1, 2025, 00:00

  • PCR148 Study of Patient Preferences Regarding a New Class of Antihypertensive Medications: A Discrete Choice Experiment in Ukraine

    Jul 1, 2025, 00:00

  • EE284 Is Every Peripheral Catheter the Same? Economic Burden and Budget Impact of Accidents and Phlebitis in Peripheral Venous Access According to Catheter Material and Safety Device

    Jul 1, 2025, 00:00

  • HTA72 Payer Perspectives on ICER Evidence Reports: InsightsInto Utility for Coverage and Formulary Decision-Making

    Jul 1, 2025, 00:00

  • EE276 Economic Evaluation of Detection, Treatment, and Prevention Interventions for Perinatal Mood and Anxiety Disorders: A Systematic Literature Review

    Jul 1, 2025, 00:00

  • PCR144 Weight Loss Program (WLP): Clinical and Economic Impact Analysis (CEIA) Preliminary Data From an MCDA Related to the Adherence of Obese Patients' Study in BraziL/LATAM/LMIC

    Jul 1, 2025, 00:00

  • PCR114 Mapping Health-Related Quality of Life (HRQoL) Measures to Preference Based Measures in Metastatic Hormone Sensitive Prostate Cancer (mHSPC): A systematic literature review

    Jul 1, 2025, 00:00

  • HPR121 What Drug Characteristics Explain the Wide range of Manufacturer Rebates?

    Jul 1, 2025, 00:00

  • PCR122 A Critical Review of Existing Shared Decision-Making Measuring Approaches in Studies Using the Medical Expenditure Panel Survey (MEPS)

    Jul 1, 2025, 00:00

  • MT24 Health Equity and Robotic-Assisted Surgery with the da Vinci Surgical Systems: A Literature Review

    Jul 1, 2025, 00:00

  • RWD25 Use of Patient Support Program Data for Real-World Evidence Generation: Opportunities and Pitfalls Illustrated in a Case Study Assessing Trastuzumab Deruxtecan Among Patients With Breast Cancer

    Jul 1, 2025, 00:00

  • HTA98 Mapping of Health Technology Assessment in China: Progress and Challenges from a Nationwide Repeated Cross-Sectional Survey

    Jul 1, 2025, 00:00

  • HSD96 Conceptualisation and the Role of Market Access in Pharmaceutical Industry: A Qualitative Study

    Jul 1, 2025, 00:00

  • RWD51 Trends in the Uptake of SGLT-2 Inhibitors in Type 2 Diabetes Mellitus With Comorbid Cardiovascular Conditions: A Longitudinal Analysis

    Jul 1, 2025, 00:00

  • RWD62 Productivity Loss And Indirect Costs Of Heart Failure: Analysis Of The Brazilian Social Security System

    Jul 1, 2025, 00:00

  • MT19 Exploring Patient Perceptions on an eHealth Application and Health Management Module in Hong Kong: A Qualitative Investigation

    Jul 1, 2025, 00:00

  • MSR81 Imputing Breast Cancer Stage in a Large EHR Dataset: Light Gradient Boosting Machine Algorithm and Explainable Artificial Intelligence

    Jul 1, 2025, 00:00

  • EE523 Incremental Annual State Level Cost Of Asthma And Future Projections In The United States

    Jul 1, 2025, 00:00

  • CO96 Development of a Patient Reported Outcome Measure for GastroIntestinal Recoveryafter Surgery (PRO-diGI)

    Jul 1, 2025, 00:00

  • Author Reply

    Jul 1, 2025, 00:00

  • EPH181 Recent Evidence on the Comprehensive Burden of Pediatric Invasive Meningococcal Disease in the United States: A Systematic Literature Review

    Jul 1, 2025, 00:00

  • PCR181 Patient-Reported Outcomes As Important Predictors of Apremilast Persisten A Pooled Analysis of Real-World Data

    Jul 1, 2025, 00:00

  • HSD101 Treatment Patterns in the Management of Alopecia Areata in a Colombian HMO During 2015-2023: A Real-World Data Study

    Jul 1, 2025, 00:00

  • EPH133 Targeted Literature Review and Qualitative Synthesis of the Burden of Oral Corticosteroid-Related Adverse Events in Autoimmune Conditions

    Jul 1, 2025, 00:00

  • PCR110 Exploring Treatment Preferences for Rare Diseases: A Systematic Review of Quantitative Preference Studies

    Jul 1, 2025, 00:00

  • EE396 Cost Per Responder Analysis of Patients With 3 Previous Lines and Lenalidomide Refractory Multiple Myeloma Who Received Cilta-Cel in the Brazilian Private Health System

    Jul 1, 2025, 00:00

  • HTA87 Study on Online Tools of Pharmacoeconomic Model Construction and Value Communication

    Jul 1, 2025, 00:00

  • EE314 Cost-Effectiveness Analysis of HIV Prevention and Treatment Portfolios in US Prison Settings

    Jul 1, 2025, 00:00

  • MSR86 Machine Learning for Predictive Modeling of Hospitalization Risk in Myasthenia Gravis Patients Using the MGFA Global Patient Registry: Addressing Imbalanced Data in Real-World Evidence Scenarios

    Jul 1, 2025, 00:00

  • HTA24 Long-term Predictions for Radical Prostatectomy versus Watchful Waiting in Early Prostate Cancer: 40-year Period Extrapolation

    Jul 1, 2025, 00:00

  • EE206 Cost-Effectiveness of a Hypothetical Dementia Prevention Treatment for Stroke Survivors

    Jul 1, 2025, 00:00

  • HSD45 US Physician Characteristics Associated With Real-World Evidence Implementation in Oncology Practice

    Jul 1, 2025, 00:00

  • EE397 Cost-Effectiveness of a Potential Policy to Ban Alcohol Advertising in Australia: A Modeling Study

    Jul 1, 2025, 00:00

  • RWD110 Validation of Real-World Pathologic Complete Response in Early Stage Triple Negative Breast Cancer

    Jul 1, 2025, 00:00

  • HSD5 Assessment of Willingness and Influencing Factors for COVID-19 Booster Vaccination Among Residents of Hong Kong in the Post-Pandemic Context

    Jul 1, 2025, 00:00

  • HSD114 Access and Quality of Usual Source of Care and Racial/Ethnic Disparities in US Adults with Multiple Chronic Conditions

    Jul 1, 2025, 00:00

  • P59 Application of Bayesian Meta-Analysis in Synthesizing Health State Utility Values for QALY Estimation in Health Economic Evaluations: A Case Study on Advanced Neuroendocrine Tumors

    Jul 1, 2025, 00:00

  • PCR209 Impact of COVID-19 on Quality of Life and Work Productivity Among Symptomatic US Adults Testing Positive for SARS-CoV-2: Interim Analysis of a Nationwide Longitudinal Study

    Jul 1, 2025, 00:00

  • HSD74 Comparison of Machine Learning Models To Predict US Adolescent Mentalhealth Trends

    Jul 1, 2025, 00:00

  • EE256 Cost-Utility Analysis of Lorlatinib in First-Line Treatment of adult patients with ALK-Positive Advanced Non-Small Cell Lung Cancer (aNSCLC) in Colombia

    Jul 1, 2025, 00:00

  • HPR71 Evaluating the ICER Special Report in the Context of Medicare Drug Price Negotiations: Implications for Manufacturer Pricing and Evidence Strategies

    Jul 1, 2025, 00:00

  • CO47 Comparative Effectiveness of Novel vs Established Therapies in Obstructive Hypertrophic Cardiomyopathy (HOCM): Insights From a US Electronic Health Records (EHR) Study

    Jul 1, 2025, 00:00

  • RWD168 Burden of Illness in CIDP: Results of a Multinational Real-World Survey

    Jul 1, 2025, 00:00

  • HPR46 Gender Differences in Use of Cerebrospinal Fluid Biomarker Test and Positron Emission Tomography for Diagnosing Mild Cognitive Impairment, Alzheimer's Disease, and Other Dementias in the Real World Setting

    Jul 1, 2025, 00:00

  • MSR71 Joint Modeling for Clinical Interpretation of ctDNA Tumor Methylation Dynamics During Longitudinal Monitoring

    Jul 1, 2025, 00:00

  • EE273 Cost-Effectiveness of Integrating Artificial Intelligence-Based Retinal Photographic Cardiovascular Disease risk Assessment with Diabetic Retinopathy Screening Programmes: A Multi-Country Analysis

    Jul 1, 2025, 00:00

  • EPH100 Acute eGFR Dip with SGLT2 Inhibitors vs. Other Antihyperglycemic Medications Among People with HIV

    Jul 1, 2025, 00:00

  • SA4 Relationship Between Event-Free Survival (EFS) and Overall Survival (OS) in Newly Diagnosed Patients With Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma (LA-HNSCC)

    Jul 1, 2025, 00:00

  • P29 Real-World Treatment Patterns of Advanced Melanoma in the United States

    Jul 1, 2025, 00:00

  • Cost-Utility Analysis of Durvalumab and Tremelimumab Versus Best Supportive Care in Refractory Metastatic Colorectal Cancer

    Jul 1, 2025, 00:00

  • EE486 PICC Line (PICC) or Central Inserted Venous Catheter (CICC ) in Cancer Patients: Comparative Effectiveness and Cost-Effectiveness Analysis in Brasil/LATAM/LMIC

    Jul 1, 2025, 00:00

  • HTA81 Development of a Novel Value Framework for Evaluating Population Genomic Programs Using A Mixed Methods Approach

    Jul 1, 2025, 00:00

  • RWD72 Utilizing NLP to Enhance EHR Data Abstraction Accuracy in Waldenström Macroglobulinemia

    Jul 1, 2025, 00:00

  • MT37 Comparative Effectiveness of Powered Surgical Stapling in Patients Undergoing Minimally Invasive Thoracic Surgery

    Jul 1, 2025, 00:00

  • HPR108 Trends in the Prescribing and Dispensing of GLP-1 Anti-Obesity Medications Among U.S. Adults with Cardiovascular Disease and Overweight or Obesity, 2021-2024

    Jul 1, 2025, 00:00

  • RWD42 Predictive Models and Risk Scoring System Development for Assessing Survival in Uterine Cancer Patients With Type 2 Diabetes Mellitus: A Territory-Wide Cohort Study

    Jul 1, 2025, 00:00

  • CO28 Understanding Racial Differences in Emergency Room Visits for Patients with Lupus

    Jul 1, 2025, 00:00

  • PCR234 Health-Related Quality of Life in Individuals with Diagnosed Depression, Self-Reported Depression, and Non-Depressed: A Multi-Center Cross-Sectional Study

    Jul 1, 2025, 00:00

  • EPH67 Association between Polypharmacy and Cognitive Limitations among Adults with Depression in the United States

    Jul 1, 2025, 00:00

  • PT34 Response Performance of General Chinese Children Aged 6-11 to EQ-5D-Y-3L: A Multicenter Study

    Jul 1, 2025, 00:00

  • PCR102 Information-Seeking Behavior of Over-the-Counter Medication From 2012 to 2022 Based Google Trends Data in Hungary

    Jul 1, 2025, 00:00

  • HPR163 Inequities in Access to Oncology Drugs in Brazil - the Case of Public and Private Healthcare Systems

    Jul 1, 2025, 00:00

  • Economic Evaluation Results Are Substantially Affected by Parameter Input Correlation

    Jul 1, 2025, 00:00

  • PCR170 Post-DCE Qualitative Interviews: A Novel Method to Understand the Rationale for Stated Preferences - An Example Among Patients and Physicians in Severe Asthma

    Jul 1, 2025, 00:00

  • PT6 Comparison of Meaningful Score Difference Estimates From Longitudinal Item Response Theory and Anchor-Based Methods

    Jul 1, 2025, 00:00

  • EE449 Cost-Effectiveness of Pembrolizumab as Treatment forFIGO 2014Stage III-IVA Cervical Cancer in the United States

    Jul 1, 2025, 00:00

  • PCR121 Elephant in the Room: Gap Between the Awareness and Need for Psycho-Social Support for Czech Lymphoma Patients as Captured Through the Analyzes of Social and Traditional Media

    Jul 1, 2025, 00:00

  • PCR104 A Conceptual Model of Multiple Myeloma Symptoms and Impacts, and A Characterization of Pain Among Patients Living With Relapsed/Refractory Multiple Myeloma

    Jul 1, 2025, 00:00

  • RWD63 Real-World Patient Persistence and Adheren A Comparison Of Long Acting Injectables and Oral Antipsychotics Used For The Treatment Of Schizophrenia in a Canadian Adult population

    Jul 1, 2025, 00:00

  • RWD132 Onset of Cardiomyopathy and Cardiovascular Disease-Related Burden in Friedreich Ataxia: Real-World Data From Medical Claims

    Jul 1, 2025, 00:00

  • PCR225 Psychometric Validation and Meaningful Within-Patient Change of the FAACT-5IASS in Patients With Cancer Cachexia

    Jul 1, 2025, 00:00

  • CO19 Adherence to Nucleos(t)ide Analog Therapies in Chronic Hepatitis B: A Systematic Review

    Jul 1, 2025, 00:00

  • HPR159 Problems in the Drug System Related to Household Medicine Classification Criteria: A Gap Analysis for Modernizing the Criteria

    Jul 1, 2025, 00:00

  • EE307 Population Impact Model of Faricimab and Aflibercept 8mg among US patients with Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration

    Jul 1, 2025, 00:00

  • MSR49 The Quantification of Efficacy and Accuracy for Screening and Data Extraction in Perinatal Mood and Anxiety Disorders Studies: A Comparative Analysis of Traditional vs. GenAI-Powered Approaches

    Jul 1, 2025, 00:00

  • EPH27 Health and Economic Value of Pneumococcal Conjugate Vaccine Against Antimicrobial Resistance in Brazil: An Agent-based Simulation Study

    Jul 1, 2025, 00:00

  • EE342 Healthcare Utilization and Cost of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Ontario, Canada: An Observational Study

    Jul 1, 2025, 00:00

  • P14 Evaluating Fairness Across Machine Learning Algorithms in Health Models Incorporating Race/Ethnicity as Predictors

    Jul 1, 2025, 00:00

  • P21 Evaluating the Performance of Claude 3.5 Sonnet in Data Extraction Automation for Systematic Literature Reviews (SLRs)

    Jul 1, 2025, 00:00

  • CO65 Real-world Impact of Semaglutide, Liraglutide, and Tirzepatide on Weight Loss and Cardiometabolic Lab Measures: A Look into Drug Persistence and Reasons for Discontinuation (r/dc)

    Jul 1, 2025, 00:00

  • PCR175 Are Cancer Trials Aligned With FDA's 2021 Guidance on Patient-Reported Outcomes?

    Jul 1, 2025, 00:00

  • EE378 Healthcare Resource Utilization and Associated Costs in Patients With Transthyretin Cardiac Amyloidosis and Non-amyloid Heart Failure

    Jul 1, 2025, 00:00

  • HPR95 Participation in a Patient Support Program is Associated With Improved Access to Efgartigimod Treatment for Generalized Myasthenia Gravis in Patients Facing Social Determinants of Health (SDOH) Challenges

    Jul 1, 2025, 00:00

  • PCR250 Burden of COVID-19 on Health-Related Quality of Life in Immunocompromised Adult Participants From the EPIC-IC Trial

    Jul 1, 2025, 00:00

  • RWD43 Public Awareness and Perspectives on Respiratory Syncytial Virus Vaccination in Hong Kong: A Comprehensive Population-Based Study

    Jul 1, 2025, 00:00

  • RWD26 Market Size and Dispensing Patterns for Rheumatoid Arthritis Medications in SUS (Brazil, 2019–2023)

    Jul 1, 2025, 00:00

  • MSR113 Target Aggregate Data Adjustment Method (TADA): A Solution for Performing Transportability Analysis with Only Aggregate-Level Data in the Target Population

    Jul 1, 2025, 00:00

  • MSR89 Machine Learning Algorithms for Identifying Undiagnosed Nonalcoholic Steatohepatitis: A Veterans Affairs Health System Study

    Jul 1, 2025, 00:00

  • HPR7 Software as a Medical Devi Current Regulations in North America and Europe

    Jul 1, 2025, 00:00

  • EE491 Automating Health Economic Model Quality Check With a Model Generator

    Jul 1, 2025, 00:00

  • PCR72 Optimizing Communication Strategies for COPD Management: Effectiveness of Educational Video and Pamphlet Interventions

    Jul 1, 2025, 00:00

  • EE425 Economic Impact of Trastuzumab and Its Biosimilars for the Treatment of HER2-Positive Breast Cancer Patients: A Real-World Study in the US

    Jul 1, 2025, 00:00

  • HPR151 Comparing the Differences in MentalHealthcare Coverage Between US Public and Private Healthcare Insurers

    Jul 1, 2025, 00:00

  • RWD73 Use of Sensitivity Analysis to Address Potential Missing Data and Selection Bias from Linked Genomics Datasets in a Real-World Study of Patients Receiving Immune-Checkpoint Inhibitors for Metastatic Melanoma

    Jul 1, 2025, 00:00

  • EE213 Cost-Utility analysis of Dinutuximab Beta in Treating High-Risk Neuroblastoma: A Partitioned Survival Model Using R programming Language

    Jul 1, 2025, 00:00

  • EPH82 Association of Systemic Lupus Erythematosus and Psychosocial Outcomes: Analysis of a Nationally Representative Data, 2017-2022

    Jul 1, 2025, 00:00

  • HPR167 Understanding How Formulary Pricing Models Shape Medication Accessibility and Financial Burden for Aging Populations

    Jul 1, 2025, 00:00

  • CO12 Long-term Health Outcomes in Patients With Moderate-to-Severe Ulcerative Colitis Treated With Guselkumab: a Model-based Projection

    Jul 1, 2025, 00:00

  • SA5 Systematic Literature Review of Unmet Needs and Burden of Disease in Generalized Anxiety Disorder (GAD)

    Jul 1, 2025, 00:00

  • CO31 Systematic Literature Review of Recombinant C1 Esterase Inhibitor (rhC1-INH) and Other Products for the On-Demand Treatment of Hereditary Angioedema Attacks

    Jul 1, 2025, 00:00

  • PCR113 One Size Doesn’t Fit All: Learnings from a Pilot Survey Assessing Preferences for Improvement vs Worsening of Healthcare Professionals

    Jul 1, 2025, 00:00

  • PCR254 Symptom Burden of Acute Influenza Infection Among US Adults: An Interim Analysis of a Nationwide Prospective Study

    Jul 1, 2025, 00:00

  • EE261 Cost-Effectiveness of Tumor-Treating Fields in Combination With Temozolomide for Glioblastoma Patients: An Italian Healthcare System Perspective

    Jul 1, 2025, 00:00

  • HTA30 Incorporating Caregiver Burden in Japans Cost-Effectiveness Evaluation: A Case Study of Teduglutide for Pediatric Short Bowel Syndrome

    Jul 1, 2025, 00:00

  • EE401 Return on Investment and Waste Considerations for the Implementation of Rechargeable Batteries in Video Laryngoscopes

    Jul 1, 2025, 00:00

  • HSD13 Exploring Oral Skeletal Muscle Relaxant Therapy in Adult Poststroke Patients in the US

    Jul 1, 2025, 00:00

  • EE415 Cost-Utility Analysis of Migraine Prevention Treatments for Chronic Migraine Headaches Patients in the United States

    Jul 1, 2025, 00:00

  • HPR155 Factors Responsible for Successful Value-Based Agreements and Barriers for Their Adoption in the United States

    Jul 1, 2025, 00:00

  • HTA43 Assessing the Added Value of Fixed-Dose Combinations in Non-Communicable Diseases: A Comparative HTA Analysis Across Canada, Scotland, France, and Germany (2014-2024)

    Jul 1, 2025, 00:00

  • MSR127 The Role of Absolute Summaries in Detecting Intransitivity and Model Mis-Specification in Indirect Treatment Comparisons

    Jul 1, 2025, 00:00

  • RWD94 Challenges in Projecting Treatment Journeys for ALK-mutated NSCLC: Addressing Uncertainty in PPS and Immature Overall Survival Data

    Jul 1, 2025, 00:00

  • HTA4 The Use of QALYs in Decision-Making in Europe, Canada, and the US: A Qualitative Review of Methodological Guidance

    Jul 1, 2025, 00:00

  • RWD140 Validity of Diagnostic Codes to Identify Metastatic Prostate Cancer in Medicare Claims Database

    Jul 1, 2025, 00:00

  • PT21 US Commercial Health Plan Coverage of Oncology Therapies: 2017 - 2024

    Jul 1, 2025, 00:00
  • 1 (current)
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • »